NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Conditions: Non-rhabdomyosarcoma; Adipocytic Neoplasm; Liposarcoma Interventions: Procedure: Surgical resection; Radiation: Proton beam radiation therapy; Drug: Pazopanib; Drug: Ifosfamide; Drug: Doxorubicin; Drug: Selinexor Sponsors: St. Jude Children ' s Research Hospital Not yet recruiting (Source:
Source: - February 2, 2024 Category: Research Source Type: clinical trials

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Conditions: Hepatoblastoma; Hepatocellular Carcinoma; Wilms Tumor; Malignant Rhabdoid Tumor; Yolk Sac Tumor; Rhabdomyosarcoma; Liposarcoma; Embryonal Sarcoma of Liver Interventions: Genetic: 21.15.GPC3-CAR T cells Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine Not yet recruiting (Source:
Source: - January 10, 2024 Category: Research Source Type: clinical trials

Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
Conditions: Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma Interventions: Biological: Peptide vaccine IPX Sponsors: University Hospital Tuebingen; Deutsches Konsortium f ürTranslationale Krebsforschung (DKTK); Cooperative Ewing Sarkom Studiengruppe; Cooperative Weichteilsarkom Study Group Recruiting (Source:
Source: - October 23, 2023 Category: Research Source Type: clinical trials

Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma
Conditions:   Alveolar Childhood Rhabdomyosarcoma;   Embryonal Childhood Rhabdomyosarcoma;   Recurrent Childhood Rhabdomyosarcoma Intervention:   Sponsors:   Shandong First Medical University;   Shandong Tumor Hospital Completed (Source:
Source: - September 15, 2023 Category: Research Source Type: clinical trials

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Condition:   Rhabdomyosarcoma Intervention:   Sponsor:   Power Life Sciences Inc. Not yet recruiting (Source:
Source: - September 8, 2023 Category: Research Source Type: clinical trials